Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2017 08:30 ET | Source: Corcept Therapeutics

Corcept Therapeutics Announces Presentations on Mifepristone for the Treatment of Patients with Hypercortisolism at the American Association of Clinical Endocrinologists 26th Annual Congress

MENLO PARK, CA--(Marketwired - May 4, 2017) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that...
May 01, 2017 16:05 ET | Source: Corcept Therapeutics

Corcept Therapeutics Announces First Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update

MENLO PARK, CA--(Marketwired - May 1, 2017) - Corcept Therapeutics Incorporated (NASDAQ: CORT) Revenue of $27.6 million in the first quarter of 2017, a 72 percent...
April 24, 2017 16:05 ET | Source: Corcept Therapeutics

Corcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call

MENLO PARK, CA--(Marketwired - Apr 24, 2017) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on May...
March 06, 2017 08:30 ET | Source: Corcept Therapeutics

Corcept Therapeutics Announces Fourth Quarter and Full-Year 2016 Financial Results; Increases 2017 Revenue Guidance

MENLO PARK, CA--(Marketwired - Mar 6, 2017) - Corcept Therapeutics Incorporated (NASDAQ: CORT) 2016 revenue of $81.3 million, a 62 percent increase from 2015 ...
January 30, 2017 16:05 ET | Source: Corcept Therapeutics

Corcept Therapeutics Announces Preliminary Fourth Quarter and Full-Year 2016 Financial Results and Corporate Update; Provides 2017 Revenue Guidance

MENLO PARK, CA--(Marketwired - Jan 30, 2017) - Corcept Therapeutics Incorporated (NASDAQ: CORT) 2016 revenue of $81.3 million, a 62 percent increase from 2015 ...
January 23, 2017 16:05 ET | Source: Corcept Therapeutics

Corcept Therapeutics to Announce Preliminary 2016 Financial Results, Provide 2017 Revenue Guidance and Corporate Update, and Host Conference Call

MENLO PARK, CA--(Marketwired - Jan 23, 2017) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report preliminary fourth quarter and full year 2016 financial results and...
December 10, 2016 08:30 ET | Source: Corcept Therapeutics

Corcept Therapeutics Announces Encouraging Results of Phase 1/2 Trial of Mifepristone Plus Eribulin in Triple-Negative Breast Cancer

MENLO PARK, CA--(Marketwired - Dec 10, 2016) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that...
November 01, 2016 16:05 ET | Source: Corcept Therapeutics

Corcept Therapeutics Announces Third Quarter 2016 Financial Results and Provides Corporate Update

MENLO PARK, CA--(Marketwired - Nov 1, 2016) - Corcept Therapeutics Incorporated (NASDAQ: CORT) Financial Highlights Third quarter revenue of $21.7 million, a...
October 26, 2016 08:30 ET | Source: Corcept Therapeutics

Corcept Therapeutics to Announce Third Quarter 2016 Financial Results and Corporate Update and Host Conference Call

MENLO PARK, CA--(Marketwired - Oct 26, 2016) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter financial results and provide a corporate update...
August 02, 2016 16:05 ET | Source: Corcept Therapeutics

Corcept Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update

MENLO PARK, CA--(Marketwired - Aug 2, 2016) - Corcept Therapeutics Incorporated (NASDAQ: CORT) Second quarter revenue of $19.7 million, a 65 percent increase from the...